Arch Biopartners Inc.
Arch Biopartners Inc.
CSE Index:
Currency:
Arch Biopartners is a portfolio based biotechnology company established to develop new products and technology for sale to pharmaceutical and industrial companies. The Company’s lead technology, MetaMx, targets brain tumor initiating cells for the purpose of developing new imaging, diagnostic and therapeutic treatments for malignant glioma.
Arch Biopartners Inc. (ACH)
SEDAR Information
Company Info
Address
27 St. Clair Ave East P.O. Box 305
Toronto, ON M4T 2M5
CanadaPhone
1-647-428-7031Email
[email protected]Website
http://www.archbiopartners.comListing date
Friday, May 7, 2010Investor Relations
n/aAuditor
EXG Chartered AccountantsCapitalization
Issued & Outstanding:
50975179Reserved for Issuance:
2024500News Releases
Bulletins
